Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
PT 101 CH FINAL
| Term | Definition |
|---|---|
| Panacea | a cure-all (from the Greek panakeia, same meaning) |
| Pharmacology | the study of drugs-their properties, uses, application, and effects |
| Antibiotic | a substance that harms or kills microorganisms like bacteria and fungi |
| Synthetic | combining simpler chemicals into more complex compounds, creating a new chemical not found in nature |
| materia medica | generally pharmacolly, but also refers to the drugs in use |
| pharmaceutics | of or about drugs; also, a drug product |
| antitoxin | a substance that acts against a toxin in the body; also a vacicine containing antitoxins, used to fight disease. |
| hormones | chemicals produced by the body that regulate body functions and processes |
| human genome | the complete set of genetic material contained in a human cell |
| data | information that is entered into and stored in a computer system |
| professional | individuals who receive extensive and advanced levels of education before being allowed to practice, such as physicians and pharmacists |
| scope of pratice | what individuals may and may not do in their jobs |
| technician | individuals who are given a basic level of training designed to help them perform specific tasks |
| confidentiality | the requirement of health care providers to keep all patient information private among the patient, the patient's insurer, and the providers directly involved in ther patient's care |
| personal inventory | an assessment of one's characteristics, skills, qualities,etc |
| competent | being qualified and capable |
| certification | a legal document certifying that an individual meets certain objective standards, usually provided by neutral professional organization |
| pediatric | having to do with the treatment of children |
| placebo | an inactive substance given in place of a medication |
| pharmaceutical equivalent | drug products that contain identical amounts of the same active ingredients in the same dosage form |
| product labeling | important associated information that is not on the label of a drug product itself, but is provided with the product in the form of an insert, brochure, or other document |
| therapeutic equivalent | pharmaceutical equivalents that produce the same effects in patients |
| Combat Methamphetamine Epidemic Act (CMEA) | federal law that sets daily and monthly limits on OTC sale of pseudoephedrine and ephedrine |
| Dual marketing | status of medications like Plan B that are classified as both prescription drugs and OTC drugs |
| Exempt narcotics | medications with habit forming ingredients that could be dispensed by pharmacist without a prescription to person at least 18 yrs of age |
| controlled substance mark (CII-CV) | that indicates the control category of a drug witha potential for abuse |
| controlled substances | five groups of drugs identified by the 1970 Controlled Substances Act (CSA) as having the potential for abuse and whose distribution is therefore strictly controlled by five control schedules set forth in the CSA |
| DEA Form 222 | U.S Official order forms-schedule I & II |
| DEA Form 224 | Application for new registration |
| adverse effect | an unintended side effectof a medication that is negative or in some way injurious to a petient's health |
| injunction | a court order preventing a specific action, such as the distribution of a potentially dangerous drug |
| recall | the action taken to remove a drug from the market and have it returned to the manufacturer |
| Class I | Where is a strong likelihood that the product will cause serious adverse effects or death |
| Class II | Where a product may cause temporary but reversible adverse effects or in which there is little likelihood of serious adverse effects |
| Class III | Where a product is not likely to cause adverse effects |
| compliance | doing what is required |
| protocol | specific guideline for practice |
| liability | legal responsibility for costs or damages arising from misconduct or negligence |
| negligence | failing to do something that should or must be done |
| ethics | a branch of philosophy that helps dtermine what should be done in a principled sense |
Created by:
lindy83
Popular Pharmacology sets